Innovative partnerships that provide bespoke solutions for specialty medicines throughout the lifecycle.

Commercial Partnerships

Partnering with pharmaceutical companies to develop cost effective, efficient strategic and operational solutions which maximize patient access to specialty medicines.

What sets Abacus Medicine Pharma Services apart as the partner of choice:

  • the range of services we provide at all stages of a product lifecycle
  • how we develop and deliver bespoke solutions in true partnership

This is underpinned by continued

  • investment and access to data sources, analytics and IT systems
  • innovation and expansion of distribution infrastructure, capabilities and routes to market

The  CP team’s breadth of knowledge and experience across the Pharmaceutical Industry and all of the capabilities of Abacus Medicine Pharma Services allow for the identification and implementation of innovative solutions that support our partners, physicians and patients’ unmet needs.

Our services

Pre-launch services

Market Analysis
Go-to-market Strategy
Regulatory Affairs

Logistics & Operations

Centralized Warehousing
Hub Distribution
Flexible Packaging
FMD Compliance

Sales Activities

Strategic Pricing
Tender Management
Specialist Targeting

Support Services

Account Management
Medical Information
Customer Services

Ongoing Data Services

Client Portal
Price Monitoring
Competitive Trends

Our services

Contact the Commercial Partnerships team today

The combination of experience, analytical resource and operational footprint has created the ability to deliver innovative and unique global solutions through true partnership.

Commercial Partnerships Resources

Case Study CP0001

Multi market EU launch, promotion and distribution. 

Read our case study on how Abacus Medicine Pharma Services has developed a multi market access strategy for a client to successfully launch, promote, and distribute a rare disease product in 10 EU countries. 

Case Study CP0002

Specialty Medicine EU Market Expansion: Developing a unique strategy to continue to successfully drive entry in to new EU markets.